beta-lapachone has been researched along with Urinary Bladder Neoplasms in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JI | 1 |
| Choi, DY | 1 |
| Chung, HS | 1 |
| Seo, HG | 1 |
| Woo, HJ | 1 |
| Choi, BT | 1 |
| Choi, YH | 1 |
1 other study available for beta-lapachone and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
beta-lapachone induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2 family and activation of caspases.
Topics: Apoptosis; Caspases; Cell Division; Cell Line, Tumor; Cell Survival; Enzyme Activation; Fas Ligand P | 2006 |